LAMEA Rabies Vaccine Market Size, Share & Trends Analysis Report By Prophylaxis Type (Post-exposure Prophylaxis, and Pre-exposure prophylaxis), By End User, By Application (Human, and Animal), By Product Type, By Country and Growth Forecast, 2023

List of Tables

The Latin America, Middle East and Africa Rabies Vaccine Market would witness market growth of 7.0% CAGR during the forecast period (2023-2030).

The Brazil market dominated the LAMEA Rabies Vaccine Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $33.5 Million by 2030. The Argentina market is showcasing a CAGR of 7.6% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 6.6% during (2023 - 2030).

Ongoing research focuses on improving the formulation of these vaccines to enhance their efficacy and duration of immunity. Novel adjuvants and vaccine platforms are being explored to stimulate a robust and long-lasting immune response. These advancements aim to optimize the effectiveness of rabies vaccination campaigns and reduce the frequency of booster doses, particularly in resource-constrained settings.

Technology plays a crucial role in modernizing rabies prevention efforts. Digital health solutions, including mobile applications and digital platforms, are increasingly used for surveillance, reporting, and monitoring of rabies cases. Real-time data collection allows for more agile responses to outbreaks, facilitates targeted vaccination campaigns, and contributes to the overall efficiency of rabies control programs.

Saudi Arabia enforces mandatory pet vaccination policies, requiring pet owners to ensure their animals are vaccinated against rabies. Implementing these policies contributes to a consistent demand for these vaccines, particularly in urban and suburban areas with a higher pet population in Saudi Arabia. The increasing trend of pet ownership in Saudi Arabia, particularly in urban areas, contributes to the demand for these vaccines. As more households adopt pets, responsible ownership practices, including vaccination, become integral to the well-being of animals and public health in Saudi Arabia. As a global hub, Saudi Arabia experiences cross-border travel with pets and imports of animals. Cultural values in Saudi Arabia emphasize the importance of animal welfare. Thus, due to these aspects, the market will expand across the LAMEA region in upcoming years.

Based on Prophylaxis Type, the market is segmented into Post-exposure Prophylaxis, and Pre-exposure prophylaxis. Based on End User, the market is segmented into Hospitals, Veterinary Clinics, and Others. Based on Application, the market is segmented into Human, and Animal. Based on Product Type, the market is segmented into Chick Embryo Cells Rabies Vaccine, Human Diploid Cell Vaccine, Vero cell rabies vaccine, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

Boehringer Ingelheim International GmbH
Cadila Pharmaceuticals Limited
Serum Institute of India Pvt. Ltd. (Cyrus Poonawalla Group)
Elanco Animal Health, Inc.
Zoetis, Inc.
Merck & Co., Inc.
Novartis AG
Bharat Biotech Ltd.
Sanofi S.A.
Virbac

LAMEA Rabies Vaccine Market Report Segmentation

By Prophylaxis Type

Post-exposure Prophylaxis
Pre-exposure prophylaxis

By End User

Hospitals
Veterinary Clinics
Others

By Application

Human
Animal

By Product Type

Chick Embryo Cells Rabies Vaccine
Human Diploid Cell Vaccine
Vero cell rabies vaccine
Others

By Country

Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA

Chapter 1.Market Scope & Methodology

1.1Market Definition
1.2Objectives
1.3Market Scope
1.4Segmentation
- 1.4.1LAMEA Rabies Vaccine Market, by Prophylaxis Type
- 1.4.2LAMEA Rabies Vaccine Market, by End User
- 1.4.3LAMEA Rabies Vaccine Market, by Application
- 1.4.4LAMEA Rabies Vaccine Market, by Product Type
- 1.4.5LAMEA Rabies Vaccine Market, by Country
1.5Methodology for the research

Chapter 2.Market at a Glance

2.1Key Highlights

Chapter 3.Market Overview

3.1Introduction
- 3.1.1Overview
  - 3.1.1.1Market Composition and Scenario
3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Opportunities
- 3.2.3Market Restraints
- 3.2.4Market Challenges
3.3Porter Five Forces Analysis

Chapter 4.LAMEA Rabies Vaccine Market by Prophylaxis Type

4.1LAMEA Post-exposure Prophylaxis Market by Country
4.2LAMEA Pre-exposure prophylaxis Market by Country

Chapter 5.LAMEA Rabies Vaccine Market by End User

5.1LAMEA Hospitals Market by Country
5.2LAMEA Veterinary Clinics Market by Country
5.3LAMEA Others Market by Country

Chapter 6.LAMEA Rabies Vaccine Market by Application

6.1LAMEA Human Market by Country
6.2LAMEA Animal Market by Country

Chapter 7.LAMEA Rabies Vaccine Market by Product Type

7.1LAMEA Chick Embryo Cells Rabies Vaccine Market by Country
7.2LAMEA Human Diploid Cell Vaccine Market by Country
7.3LAMEA Vero Cell Rabies Vaccine Market by Country
7.4LAMEA Others Market by Country

Chapter 8.LAMEA Rabies Vaccine Market by Country

8.1Brazil Rabies Vaccine Market
- 8.1.1Brazil Rabies Vaccine Market by Prophylaxis Type
- 8.1.2Brazil Rabies Vaccine Market by End User
- 8.1.3Brazil Rabies Vaccine Market by Application
- 8.1.4Brazil Rabies Vaccine Market by Product Type
8.2Argentina Rabies Vaccine Market
- 8.2.1Argentina Rabies Vaccine Market by Prophylaxis Type
- 8.2.2Argentina Rabies Vaccine Market by End User
- 8.2.3Argentina Rabies Vaccine Market by Application
- 8.2.4Argentina Rabies Vaccine Market by Product Type
8.3UAE Rabies Vaccine Market
- 8.3.1UAE Rabies Vaccine Market by Prophylaxis Type
- 8.3.2UAE Rabies Vaccine Market by End User
- 8.3.3UAE Rabies Vaccine Market by Application
- 8.3.4UAE Rabies Vaccine Market by Product Type
8.4Saudi Arabia Rabies Vaccine Market
- 8.4.1Saudi Arabia Rabies Vaccine Market by Prophylaxis Type
- 8.4.2Saudi Arabia Rabies Vaccine Market by End User
- 8.4.3Saudi Arabia Rabies Vaccine Market by Application
- 8.4.4Saudi Arabia Rabies Vaccine Market by Product Type
8.5South Africa Rabies Vaccine Market
- 8.5.1South Africa Rabies Vaccine Market by Prophylaxis Type
- 8.5.2South Africa Rabies Vaccine Market by End User
- 8.5.3South Africa Rabies Vaccine Market by Application
- 8.5.4South Africa Rabies Vaccine Market by Product Type
8.6Nigeria Rabies Vaccine Market
- 8.6.1Nigeria Rabies Vaccine Market by Prophylaxis Type
- 8.6.2Nigeria Rabies Vaccine Market by End User
- 8.6.3Nigeria Rabies Vaccine Market by Application
- 8.6.4Nigeria Rabies Vaccine Market by Product Type
8.7Rest of LAMEA Rabies Vaccine Market
- 8.7.1Rest of LAMEA Rabies Vaccine Market by Prophylaxis Type
- 8.7.2Rest of LAMEA Rabies Vaccine Market by End User
- 8.7.3Rest of LAMEA Rabies Vaccine Market by Application
- 8.7.4Rest of LAMEA Rabies Vaccine Market by Product Type

Chapter 9.Company Profiles

9.1Cadila Pharmaceuticals Limited
- 9.1.1Company Overview
- 9.1.2Recent strategies and developments:
  - 9.1.2.1Product Launches and Product Expansions:
9.2Bharat Biotech Ltd.
- 9.2.1Company Overview
9.3Serum Institute of India Pvt. Ltd. (Cyrus Poonawalla Group)
- 9.3.1Company Overview
9.4Boehringer Ingelheim International GmbH
- 9.4.1Company Overview
- 9.4.2Financial Analysis
- 9.4.3Regional & Segmental Analysis
- 9.4.4Research & Development Expenses
- 9.4.5SWOT Analysis
9.5Elanco Animal Health, Inc.
- 9.5.1Company Overview
- 9.5.2Financial Analysis
- 9.5.3Regional Analysis
- 9.5.4Research & Development Expense
- 9.5.5SWOT Analysis
9.6Zoetis, Inc.
- 9.6.1Company Overview
- 9.6.2Financial Analysis
- 9.6.3Regional Analysis
- 9.6.4Research & Development Expense
- 9.6.5SWOT Analysis
9.7Merck & Co., Inc.
- 9.7.1Company Overview
- 9.7.2Financial Analysis
- 9.7.3Segmental and Regional Analysis
- 9.7.4Research & Development Expenses
- 9.7.5SWOT Analysis
9.8Novartis AG
- 9.8.1Company Overview
- 9.8.2Financial Analysis
- 9.8.3Segmental and Regional Analysis
- 9.8.4Research & Development Expense
- 9.8.5SWOT Analysis
9.9Sanofi S.A.
- 9.9.1Company Overview
- 9.9.2Financial Analysis
- 9.9.3Segmental and Regional Analysis
- 9.9.4Research & Development Expense
- 9.9.5SWOT Analysis
9.10.Virbac
- 9.10.1Company Overview
- 9.10.2Financial Analysis
- 9.10.3Regional Analysis
- 9.10.4SWOT Analysis

LIST OF TABLES

TABLE 1LAMEA Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 2LAMEA Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 3LAMEA Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 4LAMEA Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 5LAMEA Post-exposure Prophylaxis Market by Country, 2019 - 2022, USD Million
TABLE 6LAMEA Post-exposure Prophylaxis Market by Country, 2023 - 2030, USD Million
TABLE 7LAMEA Pre-exposure prophylaxis Market by Country, 2019 - 2022, USD Million
TABLE 8LAMEA Pre-exposure prophylaxis Market by Country, 2023 - 2030, USD Million
TABLE 9LAMEA Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 10LAMEA Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 11LAMEA Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 12LAMEA Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 13LAMEA Veterinary Clinics Market by Country, 2019 - 2022, USD Million
TABLE 14LAMEA Veterinary Clinics Market by Country, 2023 - 2030, USD Million
TABLE 15LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 16LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 17LAMEA Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 18LAMEA Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 19LAMEA Human Market by Country, 2019 - 2022, USD Million
TABLE 20LAMEA Human Market by Country, 2023 - 2030, USD Million
TABLE 21LAMEA Animal Market by Country, 2019 - 2022, USD Million
TABLE 22LAMEA Animal Market by Country, 2023 - 2030, USD Million
TABLE 23LAMEA Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 24LAMEA Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 25LAMEA Chick Embryo Cells Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 26LAMEA Chick Embryo Cells Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 27LAMEA Human Diploid Cell Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 28LAMEA Human Diploid Cell Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 29LAMEA Vero Cell Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 30LAMEA Vero Cell Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 31LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 32LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 33LAMEA Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 34LAMEA Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 35Brazil Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 36Brazil Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 37Brazil Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 38Brazil Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 39Brazil Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 40Brazil Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 41Brazil Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 42Brazil Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 43Brazil Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 44Brazil Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 45Argentina Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 46Argentina Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 47Argentina Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 48Argentina Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 49Argentina Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 50Argentina Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 51Argentina Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 52Argentina Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 53Argentina Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 54Argentina Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 55UAE Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 56UAE Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 57UAE Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 58UAE Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 59UAE Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 60UAE Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 61UAE Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 62UAE Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 63UAE Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 64UAE Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 65Saudi Arabia Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 66Saudi Arabia Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 67Saudi Arabia Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 68Saudi Arabia Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 69Saudi Arabia Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 70Saudi Arabia Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 71Saudi Arabia Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 72Saudi Arabia Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 73Saudi Arabia Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 74Saudi Arabia Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 75South Africa Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 76South Africa Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 77South Africa Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 78South Africa Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 79South Africa Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 80South Africa Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 81South Africa Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 82South Africa Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 83South Africa Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 84South Africa Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 85Nigeria Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 86Nigeria Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 87Nigeria Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 88Nigeria Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 89Nigeria Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 90Nigeria Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 91Nigeria Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 92Nigeria Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 93Nigeria Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 94Nigeria Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 95Rest of LAMEA Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 96Rest of LAMEA Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 97Rest of LAMEA Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 98Rest of LAMEA Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 99Rest of LAMEA Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 100Rest of LAMEA Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 101Rest of LAMEA Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 102Rest of LAMEA Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 103Rest of LAMEA Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 104Rest of LAMEA Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 105Key Information - Cadila Pharmaceuticals Limited
TABLE 106Key Information - Bharat Biotech Ltd.
TABLE 107Key Information - Serum Institute of India Pvt. Ltd.
TABLE 108Key Information - Boehringer Ingelheim International GmbH
TABLE 109Key information - Elanco Animal Health, Inc.
TABLE 110Key Information - Zoetis, Inc.
TABLE 111Key Information - Merck & Co., Inc.
TABLE 112Key Information - Novartis AG
TABLE 113Key Information - Sanofi S.A.
TABLE 114Key Information - Virbac

LAMEA Rabies Vaccine Market Size, Share & Trends Analysis Report By Prophylaxis Type (Post-exposure Prophylaxis, and Pre-exposure prophylaxis), By End User, By Application (Human, and Animal), By Product Type, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents